ANRO Alto Neuroscience

Watchlist

2.940
0.0000.00%

Close Feb 26 16:00 ET

2.940
0.0000.00%

Post 20:01 ET

79.29MMarket Cap-1.38P/E (TTM)

About Alto Neuroscience Company

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.

Company Profile

SymbolANRO

Company NameAlto Neuroscience

Listing DateFeb 2, 2024

Issue Price16.00

Founded2019

CEODr. Amit Etkin, M.D.

MarketNYSE

Employees63

Fiscal Year Ends12-31

Address650 Castro Street,Suite 450

CityMountain View

ProvinceCalifornia

CountryUnited States of America

Zip Code94041

Phone1-650-200-0412

Websitehttp://www.altoneuroscience.com

Company Executives

Name
Position
Salary

Dr. Amit Etkin, M.D.
President, Chief Executive Officer and Chairman of the Board
1.86M

Michael Conick Hanley, Jr
Chief Operating Officer
--

Nicholas Conrad Smith
Chief Financial Officer and Principal Accounting Officer
1.60M

Adam Savitz
Chief Medical Officer
1.24M

Dr. Po Yu Chen
Independent Director
--

Andrew Dreyfus
Independent Director
107.37K

Mahalakshmi Radhakrishnan, M.D.
Independent Director
--

Christopher Nixon Cox
Independent Director
--

Gwill York
Independent Director
53.68K

Dr. Husseini Manji
Independent Director
--

ANRO Alto Neuroscience

About Alto Neuroscience Company

Company Profile

Company Executives

Trending Stocks